Additional Titles & Roles
- Director, Treatment Resistant Depression and Neurostimulation Clinic
- Director, Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders (CARRMA)
- Interventional Psychiatry Rotation Director
Education & Training
- Residency: Duke University, Durham, NC, 1999
- MD: University of Missouri, Columbia, MO, 1995
- BA: Biology: St. Louis University, St. Louis, MO, 1987
- Ziskind-Somerfeld Research Award, Society of Biological Psychiatry, 2016
- Best Doctors in America, (Best Doctors, Inc.), 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019
- Resident Faculty Teaching Award, Washington University, 2014
- Resident Mentor Award, Washington University, 2011
- NARSAD Sidney Baer Award, 2007
- Resident Faculty Teaching Award, St. Louis University, 2004, 2007
Areas of Clinical Interest
mood disorders, treatment-resistant mood disorders, bipolar disorders
treatment-resistant depression (TRD) phenomenology, novel treatments for TRD, neuroimaging of mood disorders, bipolar disorders
- Conway CR, Kumar A, Xiong W, Bunker M, Aaronson ST, Rush AJ. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression. J Clin Psychiatry. 2018; Aug 21;79(5). PMID: 30152645.
Read publication »Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
- Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality. Am J Psychiatry, 2017 Mar. PMID: 28359201.
Read publication »A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
- Conway CR, George MS, Sackeim HA. Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry, 2017. 74(1): 9-10. PMID: 27784055.
Read publication »Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough.
- Conway CR, Gebara MA, Walker MC, Lessov-Schlaggar CN, Janski AM, Chibnall JT, Cristancho P, Sheline YS, Gott BM, Svrakic DM. Clinical Characteristics and Management of Treatment-Resistant Depression. J Clin Psych, 2015; Nov; 76(11): 1569-70. PMID: 26646033.
Read publication »Clinical characteristics and management of treatment-resistant depression.
- Nagele P, Duma A, Kopec M, Gebara MA, Parsoei A, Walker M, Janski A, Panagopoulos VN, Cristancho P, Miller JP, Zorumski CF, Conway CR. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Biological Psychiatry. 2015; Jul 1; 78(1). PMID: 25577164.
Read publication »Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial.
- Conway Charles R.,Chibnall John T.,Gebara Marie Anne,Price Joseph L.,Snyder Abraham Z.,Mintun Mark A.,(Bud) Craig A.D.,Cornell Martha E.,Perantie Dana C.,Giuffra Luis A.,Bucholz Richard D.,Sheline Yvette I.,;Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression;September 2013;;
Read publication »Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression
Funded Research Projects
Lead Investigator for RECOVER national trial: A prospective, multicenter, randomized controlled, blinded trial demonstrating the safety and efficacy of Vagus Nerve Stimulation as an adjunctive therapy versus a no stimulation control in subjects with treatment-resistant depression.
American Foundation of Suicide Prevention (Co-PI). Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients.
Brain and Behavior Research Foundation (Co-I). Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies.
NIMH R21 (Co-PI). Targeting Affective Circuits Using the N-methyl-D-Aspartate (NMDA) Antagonist Nitrous Oxide.
Taylor Family Institute for Innovative Psychiatric Research (PI): Biological and Psychological Phenomenology Studies of Treatment-Resistant Depressive Disorder.